Steffen Koschmieder

Targeted DNA Methylation Analysis Facilitates Leukocyte Counts in Dried Blood Samples.

Ivan G. Costa, Tiago Maié, W. Wagner, 2023, Clinical chemistry.

Calreticulin and JAK2V617F driver mutations induce distinct mitotic defects in myeloproliferative neoplasms

Tiago Maié, Julian Baumeister, Anja Scheufen, 2024, Scientific reports.

Non-canonical Hedgehog signaling mediates profibrotic hematopoiesis-stroma crosstalk in myeloproliferative neoplasms

O. Naveiras, J. Nagai, R. Kramann, 2023, Cell reports.

Indication and management of allogeneic haematopoietic stem-cell transplantation in myelofibrosis: updated recommendations by the EBMT/ELN International Working Group.

M. Griesshammer, M. Robin, G. Barosi, 2023, The Lancet Haematology.

Exploiting Synthetic Lethality between Germline BRCA1 Haploinsufficiency and PARP Inhibition in JAK2V617F-Positive Myeloproliferative Neoplasms

Julian Baumeister, T. Brümmendorf, Nicolas Chatain, 2023, International journal of molecular sciences.

Real-world analysis of ruxolitinib in myelofibrosis: interim results focusing on patients who were naïve to JAK inhibitor therapy treated within the JAKoMo non-interventional, phase IV trial

L. Jacobasch, T. Geer, S. Isfort, 2023, Annals of Hematology.

Cell Adhesion and Local Cytokine Control on Protein-Functionalized PNIPAM-co-AAc Hydrogel Microcarriers.

J. Linkhorst, S. Rauer, Simon Wennemaring, 2024, Small.